The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 152, s67-s73
- https://doi.org/10.1016/s0022-510x(97)00247-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosisMuscle & Nerve, 1997
- Age-Dependent Penetrance of Disease in a Transgenic Mouse Model of Familial Amyotrophic Lateral SclerosisMolecular and Cellular Neuroscience, 1995
- Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosisNature, 1995
- Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutaseNature Genetics, 1995
- Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)Brain Research, 1995
- Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.Proceedings of the National Academy of Sciences, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral SclerosisJournal of Neurochemistry, 1993
- ALS, SOD and peroxynitriteNature, 1993
- Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosisCell, 1993